Tseng JC - Search Results

1

Noninvasive imaging of tumor burden and molecular pathways in mouse models of cancer.

Wang Y, Tseng JC, Sun Y, Beck AH, Kung AL. Wang Y, et al. Among authors: tseng jc. Cold Spring Harb Protoc. 2015 Feb 2;2015(2):135-44. doi: 10.1101/pdb.top069930. Cold Spring Harb Protoc. 2015. PMID: 25646505 Review.

2

Incongruity of imaging using fluorescent 2-DG conjugates compared to 18F-FDG in preclinical cancer models.

Tseng JC, Wang Y, Banerjee P, Kung AL. Tseng JC, et al. Mol Imaging Biol. 2012 Oct;14(5):553-60. doi: 10.1007/s11307-012-0545-3. Mol Imaging Biol. 2012. PMID: 22302178

3

Quantitative bioluminescence imaging of mouse tumor models.

Tseng JC, Kung AL. Tseng JC, et al. Cold Spring Harb Protoc. 2015 Jan 5;2015(1):pdb.prot078261. doi: 10.1101/pdb.prot078261. Cold Spring Harb Protoc. 2015. PMID: 25561617

4

In vivo imaging of inflammatory phagocytes.

Tseng JC, Kung AL. Tseng JC, et al. Chem Biol. 2012 Sep 21;19(9):1199-209. doi: 10.1016/j.chembiol.2012.08.007. Chem Biol. 2012. PMID: 22999887

5

In Vivo Fluorescent Labeling of Tumor Cells with the HaloTag® Technology.

Tseng JC, Benink HA, McDougall MG, Chico-Calero I, Kung AL. Tseng JC, et al. Curr Chem Genomics. 2012;6:48-54. doi: 10.2174/1875397301206010048. Epub 2012 Sep 20. Curr Chem Genomics. 2012. PMID: 23115613 Free PMC article.

6

In vivo imaging method to distinguish acute and chronic inflammation.

Tseng JC, Kung AL. Tseng JC, et al. J Vis Exp. 2013 Aug 16;(78):50690. doi: 10.3791/50690. J Vis Exp. 2013. PMID: 23978851 Free PMC article.

7

Using glow stick chemistry for biological imaging.

Tseng JC, Bailey D, Tupper T, Kung AL. Tseng JC, et al. Mol Imaging Biol. 2014 Aug;16(4):478-87. doi: 10.1007/s11307-014-0721-8. Mol Imaging Biol. 2014. PMID: 24510470

8

In vivo imaging of endogenous enzyme activities using luminescent 1,2-dioxetane compounds.

Tseng JC, Kung AL. Tseng JC, et al. J Biomed Sci. 2015 Jun 24;22(1):45. doi: 10.1186/s12929-015-0155-x. J Biomed Sci. 2015. PMID: 26100615 Free PMC article.

9

HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer.

Hideshima T, Mazitschek R, Qi J, Mimura N, Tseng JC, Kung AL, Bradner JE, Anderson KC. Hideshima T, et al. Among authors: tseng jc. Oncotarget. 2017 Jul 5;8(46):80109-80123. doi: 10.18632/oncotarget.19019. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113288 Free PMC article.

10

Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer.

Hideshima T, Mazitschek R, Qi J, Mimura N, Tseng JC, Kung AL, Bradner JE, Anderson KC. Hideshima T, et al. Among authors: tseng jc. Oncotarget. 2021 Aug 17;12(17):1736. doi: 10.18632/oncotarget.28051. eCollection 2021 Aug 17. Oncotarget. 2021. PMID: 34434504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters